These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 6817336)

  • 1. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis in five dogs with systemic immune-mediated disease.
    Matus RE; Gordon BR; Leifer CE; Saal S; Hurvitz AI
    J Am Vet Med Assoc; 1985 Sep; 187(6):595-9. PubMed ID: 4086366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of severe systemic lupus erythematosus].
    Schmidt RE; Witte T; Deicher H; Neumann KH; Schaumann D; Koch KM
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1891-3. PubMed ID: 1743102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lupus nephritis. 3: Therapeutic approach].
    Guérin S; Léveillé M
    Union Med Can; 1982 Feb; 111(2):91-5, 133. PubMed ID: 7080269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis in the treatment of extracapillary glomerulonephritis (author's transl)].
    Sanz Guajardo D; Barbolla ML; Fernández Fernández J; Gallego JL; Anaya A; Botella J
    Med Clin (Barc); 1980 May; 74(9):337-41. PubMed ID: 7382624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis combined with corticosteroids and cyclophosphamide in uncontrolled active systemic lupus erythematosus.
    Schildermans F; Dequeker J; Van de Putte I
    J Rheumatol; 1979; 6(6):687-90. PubMed ID: 529252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.
    Jones JV; Robinson MF; Parciany RK; Layfer LF; McLeod B
    Arthritis Rheum; 1981 Sep; 24(9):1113-20. PubMed ID: 6975635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term specific suppression of antibody production by plasmapheresis and a short-term course of cyclophosphamide.
    Ulrichs K; Euler HH; Schroeder JO; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):705-6. PubMed ID: 1566491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changing concepts of disseminated lupus erythematosus].
    Tron F; Bach JF
    Nouv Presse Med; 1980 Sep; 9(33):2315-8. PubMed ID: 7433021
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of lupus nephritis.
    Kaplan D; Ginzler E
    Proc Clin Dial Transplant Forum; 1974; (4):86-9. PubMed ID: 4468428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C; Müller C; Smolen J
    Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis for the treatment of severe lupus nephritis: uncontrolled observations.
    Lewis EJ
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):182-7. PubMed ID: 7102667
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmapheresis in SLE.
    Jones JV
    Clin Rheum Dis; 1982 Apr; 8(1):243-60. PubMed ID: 6214363
    [No Abstract]   [Full Text] [Related]  

  • 14. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
    Clark WF; Lindsay RM; Cattran DC; Chodirker WB; Barnes CC; Linton AL
    Can Med Assoc J; 1981 Jul; 125(2):171-4. PubMed ID: 7272867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus V: lupus nephritis.
    Blotzer JW
    Md State Med J; 1983 Nov; 32(11):851-6. PubMed ID: 6361395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lupus erythematosus and plasma exchange. A case report].
    Schildermans F; Walravens M; Dequeker J; van de Putte I
    Acta Rhumatol Belg; 1978; 2(3-4):127-31. PubMed ID: 757115
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of systemic lupus erythematosus.
    Decker JL
    Arthritis Rheum; 1982 Jul; 25(7):891-4. PubMed ID: 7104064
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lupus vasculitis].
    Kahn MF; Piette JC; Bourgeois P
    Recenti Prog Med; 1988; 79(7-8):323-9. PubMed ID: 3201028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.